<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80-vaccines-08-00273">
 <label>80.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Atasheva</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Adams</surname>
    <given-names>A.P.</given-names>
   </name>
   <name>
    <surname>Plante</surname>
    <given-names>K.S.</given-names>
   </name>
   <name>
    <surname>Ni</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Taylor</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Frolov</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Weaver</surname>
    <given-names>S.C.</given-names>
   </name>
  </person-group>
  <article-title>Chimeric Alphavirus vaccine candidates protect mice from intranasal challenge with Western equine encephalitis virus</article-title>
  <source>Vaccine</source>
  <year>2009</year>
  <volume>27</volume>
  <fpage>4309</fpage>
  <lpage>4319</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.05.011</pub-id>
  <pub-id pub-id-type="pmid">19446595</pub-id>
 </element-citation>
</ref>
